Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.

Potnis KC, Ross JS, Aneja S, Gross CP, Richman IB

Open source

DOI
10.1001/jamainternmed.2022.4969
Published
2022 Dec 1
Container
JAMA internal medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1001/jamainternmed.2022.4969,
  title = {Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.},
  author = {Potnis KC and Ross JS and Aneja S and Gross CP and Richman IB},
  year = {2022},
  journal = {JAMA internal medicine},
  doi = {10.1001/jamainternmed.2022.4969},
  url = {https://doi.org/10.1001/jamainternmed.2022.4969}
}

RIS

TY  - JOUR
TI  - Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.
AU  - Potnis KC
AU  - Ross JS
AU  - Aneja S
AU  - Gross CP
AU  - Richman IB
PY  - 2022
JO  - JAMA internal medicine
DO  - 10.1001/jamainternmed.2022.4969
UR  - https://doi.org/10.1001/jamainternmed.2022.4969
ER  - 

APA

KC, P., JS, R., S, A., CP, G., & IB, R. (2022). Artificial Intelligence in Breast Cancer Screening: Evaluation of FDA Device Regulation and Future Recommendations.. JAMA internal medicine. https://doi.org/10.1001/jamainternmed.2022.4969

Source records